January 18, 2019

Upcoming events – Allergy's long-awaited birch data and Caladrius's Treg test

Allergy Therapeutics awaits twice-delayed phase III data on its birch pollen project, while Caladrius Biosciences seeks validation of its Treg approach to type 1…

July 20, 2018

Upcoming events – FDA decision for Progenics and Allergy comes out of hiding

Progenics hopes to secure US approval for Azedra, while Allergy Therapeutics awaits phase III data with its birch vaccine.

May 21, 2018

After 11 long years Allergy sees a glimmer of hope

April 11, 2016

Interview – Allergy Therapeutics sniffs out second chance

March 18, 2014

Circassia emerges as one of the UK’s most valuable life science companies

September 17, 2012

EP Vantage Interview – Allergy competition not to be sneezed at

March 08, 2012

Hay fever vaccines entering new season of innovation

March 05, 2012

Event – Meda hoping for summer success with hay fever drug

November 27, 2009

Event – Stallergene’s Europe victory is the start of US ambitions